WO2003000269A3 - Novel use for pde 10a inhibitors - Google Patents
Novel use for pde 10a inhibitorsInfo
- Publication number
- WO2003000269A3 WO2003000269A3 PCT/EP2002/006309 EP0206309W WO03000269A3 WO 2003000269 A3 WO2003000269 A3 WO 2003000269A3 EP 0206309 W EP0206309 W EP 0206309W WO 03000269 A3 WO03000269 A3 WO 03000269A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pde
- inhibitors
- novel use
- prophylaxis
- medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2201/00—Vessel construction, in particular geometry, arrangement or size
- F17C2201/01—Shape
- F17C2201/0104—Shape cylindrical
- F17C2201/0119—Shape cylindrical with flat end-piece
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2201/00—Vessel construction, in particular geometry, arrangement or size
- F17C2201/05—Size
- F17C2201/058—Size portable (<30 l)
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2203/00—Vessel construction, in particular walls or details thereof
- F17C2203/06—Materials for walls or layers thereof; Properties or structures of walls or their materials
- F17C2203/0602—Wall structures; Special features thereof
- F17C2203/0612—Wall structures
- F17C2203/0614—Single wall
- F17C2203/0617—Single wall with one layer
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2203/00—Vessel construction, in particular walls or details thereof
- F17C2203/06—Materials for walls or layers thereof; Properties or structures of walls or their materials
- F17C2203/0634—Materials for walls or layers thereof
- F17C2203/0636—Metals
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2205/00—Vessel construction, in particular mounting arrangements, attachments or identifications means
- F17C2205/03—Fluid connections, filters, valves, closure means or other attachments
- F17C2205/0302—Fittings, valves, filters, or components in connection with the gas storage device
- F17C2205/0311—Closure means
- F17C2205/0314—Closure means breakable, e.g. with burst discs
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2209/00—Vessel construction, in particular methods of manufacturing
- F17C2209/22—Assembling processes
- F17C2209/221—Welding
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2209/00—Vessel construction, in particular methods of manufacturing
- F17C2209/22—Assembling processes
- F17C2209/228—Assembling processes by screws, bolts or rivets
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2223/00—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel
- F17C2223/01—Handled fluid before transfer, i.e. state of fluid when stored in the vessel or before transfer from the vessel characterised by the phase
- F17C2223/0107—Single phase
- F17C2223/0123—Single phase gaseous, e.g. CNG, GNC
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2260/00—Purposes of gas storage and gas handling
- F17C2260/02—Improving properties related to fluid or fluid transfer
- F17C2260/021—Avoiding over pressurising
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F17—STORING OR DISTRIBUTING GASES OR LIQUIDS
- F17C—VESSELS FOR CONTAINING OR STORING COMPRESSED, LIQUEFIED OR SOLIDIFIED GASES; FIXED-CAPACITY GAS-HOLDERS; FILLING VESSELS WITH, OR DISCHARGING FROM VESSELS, COMPRESSED, LIQUEFIED, OR SOLIDIFIED GASES
- F17C2270/00—Applications
- F17C2270/01—Applications for fluid transport or storage
- F17C2270/0165—Applications for fluid transport or storage on the road
- F17C2270/0181—Airbags
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10130151.0 | 2001-06-22 | ||
DE10130151A DE10130151A1 (en) | 2001-06-22 | 2001-06-22 | New use for PDE 10A inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003000269A2 WO2003000269A2 (en) | 2003-01-03 |
WO2003000269A3 true WO2003000269A3 (en) | 2003-04-03 |
Family
ID=7689081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/006309 WO2003000269A2 (en) | 2001-06-22 | 2002-06-10 | Novel use for pde 10a inhibitors |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE10130151A1 (en) |
WO (1) | WO2003000269A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10230605A1 (en) | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituted imidazotriazines |
DE10230604A1 (en) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclically substituted imidazotriazines |
US8338420B1 (en) | 2002-12-04 | 2012-12-25 | Mitsubishi Tanabe Pharma Corporation | Treatment of Parkinson's disease and enhancement of dopamine signal using PDE 10 inhibitor |
UA86591C2 (en) * | 2003-06-30 | 2009-05-12 | Алтана Фарма Аг | Pyrrolodihydroisoquinolines as pde10 inhibitors, pharmaceutical composition based thereon |
AU2005323794B2 (en) * | 2005-01-07 | 2012-07-19 | Pfizer Products Inc. | Heteroaromatic quinoline compounds and their use as PDE10 inhibitors |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0457671A2 (en) * | 1990-05-14 | 1991-11-21 | FIDIA S.p.A. | Dipyridamide for the treatment of diseases of the central or peripheral nervous system |
WO1995019173A1 (en) * | 1994-01-14 | 1995-07-20 | EGIS Gyógyszergyár Rt. | Pharmaceutical compositions |
WO2001024781A2 (en) * | 1999-10-07 | 2001-04-12 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulating same |
EP1250923A2 (en) * | 2001-04-20 | 2002-10-23 | Pfizer Products Inc. | Use of selective PDE10 inhibitors for the treatment of central nervous system disorders |
-
2001
- 2001-06-22 DE DE10130151A patent/DE10130151A1/en not_active Withdrawn
-
2002
- 2002-06-10 WO PCT/EP2002/006309 patent/WO2003000269A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0457671A2 (en) * | 1990-05-14 | 1991-11-21 | FIDIA S.p.A. | Dipyridamide for the treatment of diseases of the central or peripheral nervous system |
WO1995019173A1 (en) * | 1994-01-14 | 1995-07-20 | EGIS Gyógyszergyár Rt. | Pharmaceutical compositions |
WO2001024781A2 (en) * | 1999-10-07 | 2001-04-12 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulating same |
EP1250923A2 (en) * | 2001-04-20 | 2002-10-23 | Pfizer Products Inc. | Use of selective PDE10 inhibitors for the treatment of central nervous system disorders |
Non-Patent Citations (6)
Title |
---|
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2000, SEEGER T F ET AL: "PDE10A mRNA in situ hybridization mapping in the rodent brain: apparent co-localization with dopaminoceptive neurons.", XP002219920, Database accession no. PREV200100096813 * |
KOTOMI FUJISHIGE ET AL: "Cloning and Characterization of a Novel Human Phosphodiesterase that hydrolyses both cAMP and cGMP (PDE10A)", JOURNAL OF BIOLOGICAL CHEMISTRY. (MICROFILMS), AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 26, 25 June 1999 (1999-06-25), pages 18438 - 18445, XP002197149 * |
LOUGHNEY K ET AL: "Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 234, no. 1, 24 June 1999 (1999-06-24), pages 109 - 117, XP004176895, ISSN: 0378-1119 * |
MONTOLIU CARMINA ET AL: "Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons.", NEUROPHARMACOLOGY, vol. 38, no. 12, December 1999 (1999-12-01), pages 1883 - 1891, XP002219921, ISSN: 0028-3908 * |
SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 26, no. 1-2, 2000, 30th Annual Meeting of the Society of Neuroscience;New Orleans, LA, USA; November 04-09, 2000, pages Abstract No. - 345.10, ISSN: 0190-5295 * |
SODERLING ET AL: "Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, 8 June 1999 (1999-06-08), pages 7071 - 7076, XP002139277, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
DE10130151A1 (en) | 2003-01-02 |
WO2003000269A2 (en) | 2003-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003080582A3 (en) | Fredericamycin derivatives | |
DOP2002000429A (en) | IMIDAZOTRIAZINAS | |
WO2004014953A3 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
HK1087398A1 (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
WO2001078711A3 (en) | Pde-v inhibitors for treatment of parkinson's disease | |
ZA200306234B (en) | Phenethanolamine derivatives for treatment of respiratory diseases. | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
CA2458067A1 (en) | Use of flibanserin in the treatment of sexual disorders | |
ZA200604114B (en) | Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease | |
HK1128679A1 (en) | 1,2-diphenylethene derivatives for treatment of immune diseases 12- | |
WO2001098279A3 (en) | Bis-arylsulfones | |
WO2003039539A3 (en) | Use of endothelin receptor antagonists in the treatment of tumour diseases | |
AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
HK1104280A1 (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
WO2003037863A3 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
AU2002227895A1 (en) | Sulphonamides for the treatment of central nervous system diseases | |
WO2003000269A3 (en) | Novel use for pde 10a inhibitors | |
AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
AU2003289652A1 (en) | The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion | |
WO2002069944A3 (en) | Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists | |
WO2003024996A3 (en) | Antibacterial macrocycles | |
WO2005047278A3 (en) | Substituted dihydroquinazolines ii | |
WO2002074034A3 (en) | Novel medicament compositions based on anticholinergic agents and endothelin antagonists | |
EA200100876A2 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DISEASES ASSOCIATED WITH EXCESSIVE IL-12 PRODUCTION | |
WO2003011309A3 (en) | Pharmaceutical composition for treating hypercholesterolaemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW GH GM KE LS MW |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |